Merck to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual2020 Me...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
DARMSTADT, Germany, Sept. 3, 2020 /PRNewswire-AsiaNet/-- Not intended for UK and US based media- Company to present 54 abstracts across its MS portfolio - MAVENCLAD(R) (cladribine tablets), Rebif(R) (interferon beta-1a) and investigational evobrutinib - New long-term data and real-world evidence f...
Authors: LATEST ASIANET NEWS RELEASES